Companies / Vertex Pharmaceuticals Inc / Ma

Vertex Pharmaceuticals Inc / Ma

Nasdaq: VRTXCIK 875320Health CareBOSTON, MAvrtx.com ↗

Financials · FY2025

Revenue$12.00B
Net income$3.95B
Total debt$105.00M
Cash$6.14B
Diluted EPS$15.32
Shares outstanding253.5M

Ownership

253.5M shares outstanding · as of Jul 31, 2026
0.17%Insiders
Ownership
Insiders0.17%442,945
Institutions92.55%234,571,988
Public float7.28%18,445,991

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 18

View all →
Insider% of sharesShares
Kewalramani ReshmaCEOCEO & President · Director
0.04%98,278
Sachdev AmitEVP Chief Patient & Ext Af Off
0.02%55,570
Wagner Charles F JrEVP, CO & FO
0.02%47,042
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
0.02%46,763
Leiden Jeffrey MExecutive Chairman · Director
0.01%34,797
Altshuler DavidEVP, Chief Scientific Officer
0.01%34,477
Bozic CarmenEVP and CMO
0.01%33,076
Liu JoyEVP and Chief Legal Officer
<0.01%22,811
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.
<0.01%18,432
Biller JonathanEVP and Chief Legal Officer
<0.01%13,659

Institutional holders 1,656

View all →
HolderValue% of shares
BlackRock, Inc.$11.98B9.51%
Capital World Investors$11.57B10.06%
Vanguard Group Inc$10.93B9.51%
Capital Research Global Investors$7.85B6.83%
State Street Corporation$5.90B4.68%
JPMORGAN CHASE &amp; CO$2.74B2.38%
Geode Capital Management, LLC$2.73B2.42%
Capital International Investors$2.15B1.87%
Loomis, Sayles &amp; Co., L.P.$1.83B1.59%
AllianceBernstein L.P.$1.77B1.54%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 19, 2026Sachdev Amit
Executive
SellCommon Stock$9.21M-20K
-19.32%
82,124
0.03% of shares
medium
Feb 27, 2026Kewalramani Reshma
CEO
SellCommon Stock$7.72M-16K
-12.81%
105,998
0.04% of shares
medium
Feb 13, 2026Kewalramani Reshma
CEO
OtherCommon Stock$6.36M-13K
-8.90%
133,487
0.05% of shares
low
Feb 19, 2026Sachdev Amit
Executive
SellCommon Stock$5.51M-12K
-15.64%
63,171
0.02% of shares
medium
Feb 19, 2026Sachdev Amit
Executive
SellCommon Stock$4.80M-10K
-9.16%
101,786
0.04% of shares
medium
Feb 19, 2026Sachdev Amit
Executive
ExerciseCommon Stock$4.69M+25K
+27.05%
117,547
0.05% of shares
low
Jan 6, 2026Wagner Charles F Jr
Executive
SellCommon Stock$4.39M-10K
-20.17%
37,725
0.01% of shares
medium
Feb 10, 2026Kewalramani Reshma
CEO
OtherCommon Stock$3.89M-8K
-5.36%
146,528
0.06% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
Capital Research Global InvestorsPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
VRTX——92532F100—